
Professor Harry Crijns
Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))
Membership:
EHRA Member
Follow
Biography
Graduated in medicine at the University of Amsterdam in 1981, he completed his cardiology training at the University Medical Centre Groningen, The Netherlands in 1987, where he continued working as clinical cardiologist and electrophysiologist. He obtained a PhD at the University of Groningen in 1993 on 'Changes of Intracardiac Conduction Induced by Anti-arrhythmic Drugs - Importance of Use and Reverse Use-dependence'. He currently is emeritus professor of Cardiology, Maastricht University and Cardiovascular research Institute Maastricht (CARIM).
Contributions to the field include improved rate/rhythm control (RACE-trials, HATCH score), stroke prevention (CHA2DS2-VASc) and bleeding in AF (HAS-BLED). Current interests: idiopathic AF, atherothrombotic mechanisms in AF progression; hybrid AF ablation; early rhythm control in high risk AF.
Contributor content
Session
The long watch: rethinking prolonged atrial fibrillation monitoring and its clinical value
12 April 2026
Session
Atrial fibrillation: from environmental triggers to outcomes
29 August 2025
Session
How to critically appraise evidence in electrophysiology?
31 March 2025
Session
Epicardial/endocardial hybrid treatments: combining strengths, restoring rhythm
30 March 2025
Session
HOT LINE 9
1 September 2024
Session
Ask the Trialists from Hot Lines 6 and 7
28 August 2023
Session
EHRA Tracing - ECG - Day 1
16 April 2023
Session
Atrial Fibrillation - Round 1 - Drugs, Prevention
16 April 2023
Session
The year in 2022
16 April 2023
Session
Hybrid ablation: atrial fibrillation and beyond
16 April 2023

